Metis Global Partners LLC lifted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 25.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,515 shares of the pharmaceutical company’s stock after acquiring an additional 2,311 shares during the […]
Atlantic Union Bankshares Corp bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 963 shares of the pharmaceutical company’s stock, valued at approximately $303,000. Several other institutional investors also recently bought and sold […]
Vaughan Nelson Investment Management L.P. lowered its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 475,450 shares of the pharmaceutical company’s stock after selling 2,688 shares during […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a research note issued on Wednesday, Benzinga reports. They currently have a $380.00 price objective on the pharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 6.03% from the company’s current price. […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price upped by research analysts at Royal Bank of Canada from $325.00 to $343.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm presently has a “sector perform” rating on the pharmaceutical company’s stock. Royal Bank of Canada’s price target points […]